AiosynQC and IVDR-certified Aiosyn Mitosis Breast are now available through Pathomation’s AI Marketplace, building on their AWAKE project collaboration to transform kidney diagnostics with AI. Antwerp, Belgium, and Nijmegen, Netherlands...

Nijmegen, the Netherlands, and Louvain-la-Neuve, Belgium — Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, and Telemis, a specialist in medical imaging and digital pathology, today announced a...

From the Aiosyn Blog IVDR represents a significant overhaul of regulations requiring more rigorous oversight, clinical validation assessed by a Notified Body, and stricter post-market surveillance (PMS). Aiosyn’s AI-powered...

Nijmegen, the Netherlands – Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has introduced a new enhancement to its automated quality control (QC) solution, AiosynQC. The latest...

Orem, UT, and Nijmegen, Netherlands — March 20, 2025 — Techcyte, a leader in digital pathology and Aiosyn, a leading developer of AI-driven pathology algorithms, today announced a collaboration that brings Aisoyn’s AI algorithms to the...

Nijmegen, the Netherlands – Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has announced the latest advancement in its automated quality control (QC)...